Human pharmacogenomics: The development of a science
<p>Abstract</p> <p>Until about 50 years ago, the altering of a normal drug effect by a genetic deficiency was only rarely observed. Here, my discovery of the genetic variant of butyrylcholinesterase affecting succinylcholine action is described in some detail. Such discoveries led...
Main Author: | Kalow Werner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-08-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | http://www.humgenomics.com/content/1/5/375 |
Similar Items
-
Precision Medicine: Emerging Trends in Cancer Therapy
by: Rahul Badwaik
Published: (2019-10-01) -
Personalized Medicine Some Thoughts
by: Werner Kalow
Published: (2020-12-01) -
Personalized Medicine: Pharmacogenomics and Drug Development
by: Somayeh Mirsadeghi, et al.
Published: (2017-03-01) -
A Genotyping/Phenotyping Approach with Careful Clinical Monitoring to Manage the Fluoropyrimidines-Based Therapy: Clinical Cases and Systematic Review of the Literature
by: Valeria Conti, et al.
Published: (2020-09-01) -
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
by: Lally J, et al.
Published: (2016-11-01)